MYP_032395
Basic Information
T1967(FIV envelope protein (728-760))
Antimicrobial
Antiviral
Antiviral Anti-HIV Anti-HIV-1
Antiviral Anti-Retrovirus Anti-Lentivirus Anti-FIV
Antiviral Antiviral mechanism Viral fusion inhibition
Standard
33 amino acids
C174H265N45O57S
Standard
Sequence
GNITLGEWYNQTKDLQQKFYEIIMDIEQNNVQG
Physicochemical Analysis
3931.30 Da
4.18
-3.23
-3.45
-0.0980
-0.86
0.59
-0.04
59.61
79.70
0.1212
8480.00
8480.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1717.58
-16.25
55.0
55.0
135.0
277.0
5.0
41.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0311339 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
Amidation
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 | CEM4/IIIb cells; MOLT4 cells
2.518 μM
EC90
Mammalian: 30 h; Yeast: >20 h; E. coli: >10 h
RECORD: Rec_0365838 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
Amidation
Bio-Activity Profile
Antimicrobial Antiviral
Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells
2.454 μM
EC50
Showing 2 records on this page · Page 3 of 3